Clinical and laboratory evaluation of the myeloprotective effect of medroxyprogesterone acetate in head and neck cancer.

[1]  G. Morstyn.  THE IMPACT OF COLONY STIMULATING FACTORS ON CANCER CHEMOTHERAPY , 1990, British journal of haematology.

[2]  D. Metcalf.  The colony stimulating factors discovery, development, and clinical applications , 1990, Cancer.

[3]  D. Scadden,et al.  Hematopoietic growth factors. Biology and clinical applications. , 1989, The New England journal of medicine.

[4]  M. Moore,et al.  Clinical use of recombinant human hematopoietic growth factors. , 1989, Journal of the National Cancer Institute.

[5]  D. Linch,et al.  Clinical significance of the haemopoietic growth factors. , 1989, British Journal of Cancer.

[6]  M. Socinski,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. , 1988, The New England journal of medicine.

[7]  J. Singer,et al.  Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. , 1988, Blood.

[8]  J. Gutterman,et al.  Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, Blood.

[9]  Wilson Ja.  Myeloprotective effect of high dose medroxyprogesterone acetate (MPA). , 1988 .

[10]  D. Metcalf.  Granulocyte-macrophage colony-stimulating factors , 1985, Cell.

[11]  J H Goldie,et al.  The genetic origin of drug resistance in neoplasms: implications for systemic therapy. , 1984, Cancer research.

[12]  C. Perno,et al.  5-Fluorouracil, Adriamycin and Cyclophosphamide Combined with High-Dose Medroxyprogesterone Acetate in Advanced Breast Cancer , 1983, Tumori.

[13]  A. Burgess,et al.  Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. , 1977, Blood.

[14]  F. Pannuti,et al.  Massive-dose progestational therapy in oncology (medroxyprogesterone). Preliminary results. , 1976, Panminerva medica.

[15]  B. Pike,et al.  Human bone marrow colony growth in agar‐gel , 1970, Journal of cellular physiology.

[16]  D. Metcalf,et al.  The growth of mouse bone marrow cells in vitro. , 1966, The Australian journal of experimental biology and medical science.

[17]  L. Sachs,et al.  The cloning of normal "mast" cells in tissue culture. , 1965, Journal of cellular physiology.

[18]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .

[19]  S. Jagannath,et al.  Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy. , 1990, International journal of cell cloning.

[20]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.